Page last updated: 2024-08-21

2-aminopurine and Astrocytoma, Grade IV

2-aminopurine has been researched along with Astrocytoma, Grade IV in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barazas, M; De Witt Hamer, PC; Geerts, D; Gray, NS; Hagemann, C; Hiddingh, L; Kerami, M; Kessler, AF; Kwiatkowski, N; Lagerweij, T; Lewandrowski, G; Niers, JM; Nilsson, RJ; Noske, DP; Sol, N; Tannous, BA; Van der Stoop, PM; Van Tellingen, O; Vandertop, WP; Wang, J; Wedekind, L; Würdinger, T; Zhou, W	1

Other Studies

1 other study(ies) available for 2-aminopurine and Astrocytoma, Grade IV

Article	Year
Effects of the selective MPS1 inhibitor MPS1-IN-3 on glioblastoma sensitivity to antimitotic drugs. Journal of the National Cancer Institute, 2013, Sep-04, Volume: 105, Issue:17 Topics: 2-Aminopurine; Animals; Antimitotic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cell Cycle Proteins; Cell Survival; Drug Resistance, Neoplasm; France; Frozen Sections; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; M Phase Cell Cycle Checkpoints; Mice; Mice, Nude; Netherlands; ortho-Aminobenzoates; Paclitaxel; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; RNA Interference; United States; Up-Regulation; Vincristine; Xenograft Model Antitumor Assays	2013

Article

Year

Effects of the selective MPS1 inhibitor MPS1-IN-3 on glioblastoma sensitivity to antimitotic drugs.

Journal of the National Cancer Institute, 2013, Sep-04, Volume: 105, Issue:17

Topics: 2-Aminopurine; Animals; Antimitotic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cell Cycle Proteins; Cell Survival; Drug Resistance, Neoplasm; France; Frozen Sections; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; M Phase Cell Cycle Checkpoints; Mice; Mice, Nude; Netherlands; ortho-Aminobenzoates; Paclitaxel; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; RNA Interference; United States; Up-Regulation; Vincristine; Xenograft Model Antitumor Assays

2013